Lycopene - A natural antioxidant;A likopin - Egy természetes antioxidáns

Orvosi Hetilap

Volumn 146, Issue 31, 2005, Pages 1621-1624

  Bánhegyi, Gábor ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Antioxidant; Cardiovascular diseases; Carotenoid; Lycopene; Prostate cancer

Indexed keywords

ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CYCLIN D1; GAP JUNCTION PROTEIN; LYCOPENE; RETINOL; ANTINEOPLASTIC AGENT;

ARTICLE; BIOTRANSFORMATION; CANCER RISK; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; FOOD INTAKE; FOOD PROCESSING; HUMAN; HYPERTENSION; NERVE DEGENERATION; OSTEOPOROSIS; PROSTATE CANCER; PROTEIN EXPRESSION; TOMATO; ANIMAL; BIOAVAILABILITY; CHEMISTRY; CORONARY ARTERY DISEASE; DRUG EFFECT; ERYTHEMA; FOOD HANDLING; RADIATION EXPOSURE; REVIEW; SKIN; ULTRAVIOLET RADIATION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CAROTENOIDS; CORONARY DISEASE; ERYTHEMA; FOOD HANDLING; HUMANS; SKIN; ULTRAVIOLET RAYS;

EID: 27244453446     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abushita, A. A., Daood, H. G., Biacs, P. A.: Change in carotenoids and antioxidant vitamins in tomato as a function of varietal and technological factors. J. Agric. Food Chem., 2000, 48, 2075-2081.
2. Agarwal, S., Rao, A. V.: Tomato lycopcne and low density lipoprotein oxidation: a human dietary intervention study. Lipids, 1998, 33, 981-984.
3. Aman, M. S., Gupta, N. P.: Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol. Oncol., 2004, 22, 415-420.
4. Ben-Dor, A., Steiner, M., Gheber, L. és mtsai: Carotenoids activate the antioxidant response element transcription system. Mol. Cancer Ther., 2005, 4, 177-186.
5. Benzie, I. F.: Evolution of dietary antioxidants. Comp. Biochem. Physiol. A. Mol. Integr. Physiol., 2003, 136, 113-126.
6. Biacs, P. A., Daood, H. G.: Lipoxygenase-catalysed degradation of carotenoids from tomato in the presence of antioxidant vitamins. Biochem. Soc. Trans., 2000, 28, 839-845.
7. Boileau, T. W., Boileau, A. C., Erdman, J. W. Jr.: Bioavailability of all-trans and cis-isomers of lycopene. Exp. Biol. Med. (Maywood), 2002, 227, 914-919.
8. Campbell, J. K., Canene-Adams, K., Lindshield, B. L. és mtsai: Tomato phytochemicals and prostate cancer risk. J. Nutr., 2004, 134, 3486S-3492S.
9. Di Mascio, P., Kaiser, S., Sies, H.: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 1989, 274, 532-538.
10. Fazekas, Z., Gao, D., Saladi, R. N. és mtsai: Protective effects of lycopene against ultraviolet B-induced photodamage. Nutr. Cancer, 2003, 47, 181-187.
11. Gianetti, J., Pedrinelli, R., Petrucci, R. és mtsai: Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am. Heart J., 2002, 143, 467-474.
12. Giovannucci, E., Rimm, E. B.. Liu, Y. és misai: A prospective study of tomato products, lycopcne, and prostate cancer risk. J. Natl. Cancer Inst., 2002, 94, 391-398.
13. Giovannucci, E.: A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp. Biol. Med. (Maywood), 2002, 227, 852-859.
14. Gradelet, S., Astorg, P., Ledere, J. es mtsai: Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica, 1996, 26, 49-63.
15. Gruenwald, J., Jaenicke, C., Freder, J.: Lycopene. The modern answer to urban wellness? NUTRAfoods, 2003, 2, 21-35.
16. Hadley, C. W., Clinton, S. K., Schwartz, S. J.: The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J. Nutr., 2003, 133, 727-732.
17. Heber, D., Lu, Q.Y.: Overview of mechanisms of action of lycopene. Exp. Biol. Med. (Maywood), 2002, 227, 920-923.
18. Herzog, A., Siler, U., Spitzer, V. és mtsai: Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J., 2005, 19, 272-274.
19. Kohlmeier, L., Kark, J. D., Gomez-Gracia, E. és mtsai: Lycopene and myocardial infarction risk in the EURAMIC Study. Am. J. Epidemiol., 1997, 146, 618-626.
20. Lauridsen, V. S. T., Daneshvar, B., Jakobsen, J.: Dose-response effect of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett. 2000, 154, 201-210.
21. Levy, J., Sharoni, Y.: The functions of tomato lycopene and its role in human health. HerbalGram, 2004, 62, 46-56.
22. Lugasi A., Hovari J., Biro L. és mtsai: (Factors influencing lycopene content of foods, and lycopene intake of Hungarian population) Magy. Onkol., 2004, 48, 131-136.
23. Mandl, J., Bánhegyi, G., Kalapos, M. P. és mtsa: Increased oxidation and decreased conjugation of drugs in the liver caused by starvation. Altered metabolism of certain aromatic compounds and acetone. Chem. Biol. Interact., 1995, 96, 87-101.
24. Mandl J.: Biotranszformáció - mé regtelenítés. In Orvosi biokémia. Szerk.: Ádám V., Dux L., Faragó A. és mtsai. Medicina, Budapest. 2001, 297-314. old.
25. McCullough, M. L., Giovannucci, E. L.: Diet and cancer prevention. Oncogene, 2004, 23, 6349-6364.
26. Minorsky, P.V.: Lycopene and human health. Plant Physiol., 2002, 130, 1077-1078.
27. Nahum, A., Hirsch, K., Danilenko, M. és mtsai: Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene, 2001, 20, 3428-3436.
28. Paetau, I., Khachik, F., Brown, E. D. és mtsai: Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am. J. Clin. Nutr., 1998, 68, 1187-1195.
29. Rao, A. V., Agarwal, S.: Role of antioxidant lycopene in cancer and heart disease. J. Am. Coll. Nutr., 2000, 19, 563-569.
30. Rao, A. V.: Lycopene, tomatoes, and the prevention of coronary heart disease. Exp. Biol. Med. (Maywood), 2002, 227, 908-913.
31. Rao, L. G., Guns, E., Rao, A. V.: Lycopene: Its role in human health and disease. AGROFood Industry hi-tech, 2003, July/August, 25-30.
32. Ribaya Mercado, J. D., Garmyn, M., Gilchrest, B. A. és mtsa: Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans. J. Nutr., 1995, 125, 1854-1859.
33. Rissanen, T H., Voutilainen, S., Nyyssonen, K. és mtsai: Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Clin. Nutr., 2003, 77, 133-138.
34. Sesso, H. D., Buring, J. E., Norkus, E. P. és mtsa: Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am. J. Clin. Nutr., 2004, 79, 47-53.
35. Shi, J., Kakuda, Y., Yeung, D.: Antioxidative properties of lycopene and other carotenoids from tomatoes: Synergistic effects. Biofactors, 2004, 21, 203-210.
36. Stahl, W., Sies, H.: Carotenoids and protection against solar UV radiation. Skin Pharmacol. Appl. Skin Physiol., 2002, 15, 291-296.
37. Tang, L., Jin, T., Zeng, X. és mtsa: Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr., 2005, 135, 287-290.
38. Weisburger, J. H.: Lycopene and tomato products in health promotion. Exp. Biol. Med. (Maywood), 2002, 227, 924-927.
39. Wertz, K., Siler, U., Goralczyk, R.: Lycopene: modes of action to promote prostate health. Arch. Biochem. Biophys., 2004, 430, 127-134.